Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kyounghae Kim & Anna-Rae LeClaire. (2019) A systematic review of factors influencing human papillomavirus vaccination among immigrant parents in the United States. Health Care for Women International 40:6, pages 696-718.
Read now
Read now
Cristina Scavone, Cristina Di Mauro, Simona Brusco, Michele Bertini, Gabriella di Mauro, Concetta Rafaniello, Liberata Sportiello, Francesco Rossi & Annalisa Capuano. (2019) Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy. Expert Opinion on Drug Safety 18:5, pages 427-433.
Read now
Read now
Vishakha Bhurani, Aditi Mohankrishnan, Alexandre Morrot & Sarat Kumar Dalai. (2018) Developing effective vaccines: Cues from natural infection. International Reviews of Immunology 37:5, pages 249-265.
Read now
Read now
Sharon Attipoe-Dorcoo, Vedantha Singh & Jennifer Moodley. (2018) A content analysis of online news media reporting on the human papillomavirus vaccination programme in South Africa. Southern African Journal of Gynaecological Oncology 10:2, pages 19-24.
Read now
Read now
Aria C. Attia, Judith Wolf & Ana E. Núñez. (2018) On surmounting the barriers to HPV vaccination: we can do better. Annals of Medicine 50:3, pages 209-225.
Read now
Read now
Articles from other publishers (59)
Merel J Smit, Adam F Sander, Maud B P A Ariaans, Cyrielle Fougeroux, Constanze Heinzel, Rolf Fendel, Meral Esen, Peter G Kremsner, Rob ter Heine, Heiman F Wertheim, Manja Idorn, Søren Riis Paludan, Alexander P Underwood, Alekxander Binderup, Santseharay Ramirez, Jens Bukh, Max Soegaard, Sayit M Erdogan, Tobias Gustavsson, Stine Clemmensen, Thor G Theander, Ali Salanti, Mette Hamborg, Willem A de Jongh, Matthew B B McCall, Morten A Nielsen, Benjamin G Mordmüller, Merel J Smit, Adam F Sander, Maud B P A Ariaans, Cyrielle Fougeroux, Constanze Heinzel, Rolf Fendel, Meral Esen, Peter G Kremsner, Rob ter Heine, Heiman F Wertheim, Manja Idorn, Søren Riis Paludan, Alexander P Underwood, Alekxander Binderup, Santseharay Ramirez, Jens Bukh, Max Soegaard, Sayit M Erdogan, Tobias Gustavsson, Stine Clemmensen, Thor G Theander, Ali Salanti, Mette Hamborg, Willem A de Jongh, Matthew B B McCall, Morten A Nielsen, Benjamin G Mordmüller, Robert Dagil, Louise Goksøyr, Thomas M Hulen, Christoph Janitzek, Daniel S Jensen, Sune Justesen, Paul K Khalifé, Andrea Kreidenweiss, Telma Lança, Olivia Lie-Andersen, Karina Teelen & Elena Vidal-Calvo. (2023) First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2. The Lancet Microbe 4:3, pages e140-e148.
Crossref
Crossref
Hye Won Kwak, Wooseok Shin, Kyunghwa Baik, Minsun Kim, YongWook Park, So‐Hee Hong, Hyo‐Jung Park, Hyeong‐Jun Park, Yoo‐Jin Bang, Jae‐Yong Kim, Yu‐Sun Lee, In‐Beom Kim, Hong‐Lim Kim, Hun Kim & Jae‐Hwan Nam. (2022) Single‐stranded RNA adjuvant enhances the efficacy of 10‐valent human papilloma virus‐like particle vaccine. Microbiology and Immunology 66:11, pages 529-537.
Crossref
Crossref
Xuejiao Han, Aqu Alu, Hongmei Liu, Yi Shi, Xiawei Wei, Lulu Cai & Yuquan Wei. (2022) Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy. Bioactive Materials 17, pages 29-48.
Crossref
Crossref
Priyanka Sinha, Jyothi G. Seshadri & Priyadarshini Chidambaram. (2022) Effect of Health Education on Awareness of HPV Vaccination and its Acceptance Among Postpartum Women. Indian Journal of Gynecologic Oncology 20:3.
Crossref
Crossref
Megumi Kurosawa, Masayuki Sekine, Manako Yamaguchi, Risa Kudo, Sharon J. B. Hanley, Megumi Hara, Sosuke Adachi, Yutaka Ueda, Etsuko Miyagi, Sayaka Ikeda, Asami Yagi & Takayuki Enomoto. (2022) Long‐term effectiveness of HPV vaccination against HPV infection in young Japanese women: Real‐world data. Cancer Science 113:4, pages 1435-1440.
Crossref
Crossref
Silje Johansen, Ingvild Jenssen Lægreid, Siw Leiknes Ernstsen, Nessar Ahmad Azrakhsh, Astrid Olsnes Kittang, Roald Lindås, Bjørn Tore Gjertsen, Nils Vetti, Trude Victoria Mørtberg, Ingvild Hausberg Sørvoll, Pål André Holme, Maria Therese Ahlen & Håkon Reikvam. (2022) Thrombosis and thrombocytopenia after HPV vaccination. Journal of Thrombosis and Haemostasis 20:3, pages 700-704.
Crossref
Crossref
Megumi Kurosawa, Masayuki Sekine, Manako Yamaguchi, Risa Kudo, Sharon J. B. Hanley, Megumi Hara, Sosuke Adachi, Yutaka Ueda, Etsuko Miyagi, Sayaka Ikeda, Asami Yagi & Takayuki Enomoto. (2022) Long-Term Effects of Human Papillomavirus Vaccination in Clinical Trials and Real-World Data: A Systematic Review. Vaccines 10:2, pages 256.
Crossref
Crossref
Linda van Oosten, Jort J. Altenburg, Cyrielle Fougeroux, Corinne Geertsema, Fred van den End, Wendy A. C. Evers, Adrie H. Westphal, Simon Lindhoud, Willy van den Berg, Daan C. Swarts, Laurens Deurhof, Andreas Suhrbier, Thuy T. Le, Shessy Torres Morales, Sebenzile K. Myeni, Marjolein Kikkert, Adam F. Sander, Willem Adriaan de Jongh, Robert Dagil, Morten A. Nielsen, Ali Salanti, Max Søgaard, Timo M. P. Keijzer, Dolf Weijers, Michel H. M. Eppink, René H. Wijffels, Monique M. van Oers, Dirk E. Martens & Gorben P. Pijlman. (2021) Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants. mBio 12:5.
Crossref
Crossref
Colette M. Gnade, Emily K. Hill, Hannah E. Botkin, Alison R. Hefel, Hayley E. Hansen, Kelsey A. Sheets, Sarah L. Mott, Abbey J. Hardy-Fairbanks & Colleen K. Stockdale. (2021) Is the age of cervical cancer diagnosis changing over time?. Journal of Gynecology Obstetrics and Human Reproduction 50:7, pages 102040.
Crossref
Crossref
Rosa De Vincenzo, Nicola Caporale, Valentina Bertoldo, Caterina Ricci, Maria Teresa Evangelista, Nicolò Bizzarri, Luigi Pedone Anchora, Giovanni Scambia & Giovanni Capelli. (2021) HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study. Vaccines 9:6, pages 643.
Crossref
Crossref
Laurits Fredsgaard, Louise Goksøyr, Susan Thrane, Kara-Lee Aves, Thor G. Theander & Adam F. Sander. (2021) Head-to-Head Comparison of Modular Vaccines Developed Using Different Capsid Virus-Like Particle Backbones and Antigen Conjugation Systems. Vaccines 9:6, pages 539.
Crossref
Crossref
Zhuoya Wan, Ruohui Zheng, Pearl Moharil, Yuzhe Liu, Jing Chen, Runzi Sun, Xu Song & Qiang Ao. (2021) Polymeric Micelles in Cancer Immunotherapy. Molecules 26:5, pages 1220.
Crossref
Crossref
Cyrielle Fougeroux, Louise Goksøyr, Manja Idorn, Vladislav Soroka, Sebenzile K. Myeni, Robert Dagil, Christoph M. Janitzek, Max Søgaard, Kara-Lee Aves, Emma W. Horsted, Sayit Mahmut Erdoğan, Tobias Gustavsson, Jerzy Dorosz, Stine Clemmensen, Laurits Fredsgaard, Susan Thrane, Elena E. Vidal-Calvo, Paul Khalifé, Thomas M. Hulen, Swati Choudhary, Michael Theisen, Susheel K. Singh, Asier Garcia-Senosiain, Linda Van Oosten, Gorben Pijlman, Bettina Hierzberger, Tanja Domeyer, Blanka W. Nalewajek, Anette Strøbæk, Magdalena Skrzypczak, Laura F. Andersson, Søren Buus, Anette Stryhn Buus, Jan Pravsgaard Christensen, Tim J. Dalebout, Kasper Iversen, Lene H. Harritshøj, Benjamin Mordmüller, Henrik Ullum, Line S. Reinert, Willem Adriaan de Jongh, Marjolein Kikkert, Søren R. Paludan, Thor G. Theander, Morten A. Nielsen, Ali Salanti & Adam F. Sander. (2021) Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity. Nature Communications 12:1.
Crossref
Crossref
Jonathan P Segal, Alan Askari, Susan K Clark, Ailsa L Hart & Omar D Faiz. (2021) The Incidence and Prevalence of Human Papilloma Virus–associated Cancers in IBD. Inflammatory Bowel Diseases 27:1, pages 34-39.
Crossref
Crossref
Marium Salwa & Tarek Abdullah Al-Munim. 2021. Ethical Challenges in Cancer Diagnosis and Therapy. Ethical Challenges in Cancer Diagnosis and Therapy
31
37
.
Emanuele Sasso, Anna Morena D’Alise, Nicola Zambrano, Elisa Scarselli, Antonella Folgori & Alfredo Nicosia. (2020) New viral vectors for infectious diseases and cancer. Seminars in Immunology 50, pages 101430.
Crossref
Crossref
Amy Liu. (2020) HPV: Injecting Truth into the Vaccine and Making Effective Recommendations. Pediatric Annals 49:6.
Crossref
Crossref
Kara-Lee Aves, Louise Goksøyr & Adam F. Sander. (2020) Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines. Viruses 12:2, pages 185.
Crossref
Crossref
Massimo Origoni, Paolo Cristoforoni, Luciano Mariani, Silvano Costa, Mario Preti, Maria T. Sandri, Eleonora P. Preti, Alessandro Ghelardi & Antonio Perino. (2020) Vaccinare per HPV: non solo le adolescenti e non solo profilassi. Review e position paper dell'Italian HPV Study Group (IHSG). Minerva Ginecologica 71:6.
Crossref
Crossref
Z Guiqian, D Ziqin, X Ya, W Qiong, F Xin, B Limei, Z Hongyan & S Yi. (2020) Human Papillomavirus Infection Rates before and after the Introduction of Prophylactic Vaccines in Kunming, Yunnan, China. Indian Journal of Medical Microbiology 38:1, pages 66-71.
Crossref
Crossref
Ruibin Qi, Qiuhong Miao, Jie Zhu, Jingyu Tang, Aoxing Tang, Xiaoxue Wang, Dandan Dong, Hongyuan Guo & Guangqing Liu. (2020) Construction and immunogenicity of novel bivalent virus-like particles bearing VP60 genes of classic RHDV(GI.1) and RHDV2(GI.2). Veterinary Microbiology 240, pages 108529.
Crossref
Crossref
Sinan ÖZÇELİK & Fatma Arzu KILIC. (2019) Human papillomavirus vaccination: review of the current evidenceİnsan papilloma virüs aşısı: Güncel kanıtların gözden geçirilmesi. Mucosa 2:4, pages 86-94.
Crossref
Crossref
Alison B. Wiyeh, Sara Cooper, Anelisa Jaca, Edison Mavundza, Duduzile Ndwandwe & Charles S. Wiysonge. (2019) Social media and HPV vaccination: Unsolicited public comments on a Facebook post by the Western Cape Department of Health provide insights into determinants of vaccine hesitancy in South Africa. Vaccine 37:43, pages 6317-6323.
Crossref
Crossref
Andrea Su En Lim & Raymond Boon Tar Lim. (2019) Facilitators and barriers of human papillomavirus vaccine uptake in young females 18–26 years old in Singapore: A qualitative study. Vaccine 37:41, pages 6030-6038.
Crossref
Crossref
C. Raina MacIntyre, Peter J. Shaw, Fiona E. Mackie, Christina Boros, Helen Marshall, Holly Seale, Sean E. Kennedy, Aye Moa, Abrar Ahmad Chughtai, Mallory Trent, Edward V O'Loughlin & Michael Stormon. (2019) Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children. Vaccine 37:37, pages 5630-5636.
Crossref
Crossref
Jiantai Qiu, Donia Alson, Ta-Hsien Lee, Ching-Chou Tsai, Ting-Wei Yu, Yu-Sing Chen, Ya-Fang Cheng, Chu-Chi Lin & Scott Schuyler. (2019) Effect of Multiple Vaccinations with Tumor Cell-Based Vaccine with Codon-Modified GM-CSF on Tumor Growth in a Mouse Model. Cancers 11:3, pages 368.
Crossref
Crossref
Jeremy Anderson, Zheng Quan Toh, Andrea Reitsma, Lien Anh Ha Do, Jordan Nathanielsz & Paul V. Licciardi. (2019) Effect of peripheral blood mononuclear cell cryopreservation on innate and adaptive immune responses. Journal of Immunological Methods 465, pages 61-66.
Crossref
Crossref
Konstantinos Doufekas, Yaa Achampong & Adeola Olaitan. 2019. Uterine Cervical Cancer. Uterine Cervical Cancer
17
29
.
Trystan Leng & Matt J. Keeling. (2018) Concurrency of partnerships, consistency with data, and control of sexually transmitted infections. Epidemics 25, pages 35-46.
Crossref
Crossref
Maryam Dadar, Sandip Chakraborty, Kuldeep Dhama, Minakshi Prasad, Rekha Khandia, Sameer Hassan, Ashok Munjal, Ruchi Tiwari, Kumaragurubaran Karthik, Deepak Kumar, Hafiz M. N. Iqbal & Wanpen Chaicumpa. (2018) Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus. Frontiers in Immunology 9.
Crossref
Crossref
Jozica Skufca, Jukka Ollgren, Miia Artama, Esa Ruokokoski, Hanna Nohynek & Arto A. Palmu. (2018) The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland. Vaccine 36:39, pages 5926-5933.
Crossref
Crossref
Julie Mouchet, Francesco Salvo, Emanuel Raschi, Elisabetta Poluzzi, Ippazio Cosimo Antonazzo, Fabrizio De Ponti & Bernard Bégaud. (2018) Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis. Pharmacological Research 132, pages 108-118.
Crossref
Crossref
Marc Arbyn, Lan Xu, Cindy Simoens & Pierre PL Martin-Hirsch. (2018) Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database of Systematic Reviews 2020:3.
Crossref
Crossref
Thorsten Verch, Jeremiah J Trausch & Mary Shank-Retzlaff. (2018) Principles of vaccine potency assays. Bioanalysis 10:3, pages 163-180.
Crossref
Crossref
Jules J. Berman. 2018. Precision Medicine and the Reinvention of Human Disease. Precision Medicine and the Reinvention of Human Disease
327
365
.
Oliver Damm, Johannes Horn, Rafael T. Mikolajczyk, Mirjam E. E. Kretzschmar, Andreas M. Kaufmann, Yvonne Deleré, Bernhard Ultsch, Ole Wichmann, Alexander Krämer & Wolfgang Greiner. (2017) Cost-effectiveness of human papillomavirus vaccination in Germany. Cost Effectiveness and Resource Allocation 15:1.
Crossref
Crossref
Frédéric Gervais, Kyle Dunton, Yiling Jiang & Nathalie Largeron. (2017) Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend. BMC Public Health 17:1.
Crossref
Crossref
Ariel Esteban Bardach, Osvaldo Ulises Garay, María Calderón, Andrés Pichón-Riviére, Federico Augustovski, Sebastián García Martí, Paula Cortiñas, Marino Gonzalez, Laura T. Naranjo, Jorge Alberto Gomez & Joaquín Enzo Caporale. (2017) Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model. BMC Public Health 17:1.
Crossref
Crossref
Marzio Pennisi, Giulia Russo, Silvia Ravalli & Francesco Pappalardo. (2017) Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus. BMC Bioinformatics 18:S16.
Crossref
Crossref
Mona O. Mohsen, Lisha Zha, Gustavo Cabral-Miranda & Martin F. Bachmann. (2017) Major findings and recent advances in virus–like particle (VLP)-based vaccines. Seminars in Immunology 34, pages 123-132.
Crossref
Crossref
Minjin Kim, Haeok Lee, Peter Kiang & Deogwoon Kim. (2017) Human Papillomavirus: A Qualitative Study of Korean American Female College Students’ Attitudes Toward Vaccination
. Clinical Journal of Oncology Nursing 21:5, pages E239-E247.
Crossref
Crossref
Katharine A. Rendle & Emily A. Leskinen. (2016) Timing Is Everything: Exploring Parental Decisions to Delay HPV Vaccination. Qualitative Health Research 27:9, pages 1380-1390.
Crossref
Crossref
Jessica A. Kahn, Jiahong Xu, Bill G. Kapogiannis & John W. Sleasman. (2017) Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay. JAIDS Journal of Acquired Immune Deficiency Syndromes 75:2, pages 241-245.
Crossref
Crossref
Meghan Plotnick & Catherine Craig. (2017) Should HPV Vaccination Be Offered to Mid-adult Women?. Journal of Obstetrics and Gynaecology Canada 39:5, pages 361-365.
Crossref
Crossref
Romina A Tejada, Kris G Vargas, Vicente Benites-Zapata, Edward Mezones-Holguín, Rafael Bolaños-Díaz & Adrian V Hernández. (2017) Human papillomavirus vaccine efficacy in the prevention of anogenital warts: systematic review and meta-analysis. Salud Pública de México 59:1, pages 84.
Crossref
Crossref
Bonaventura C. T. Mpondo. (2016) New Biomedical Technologies and Strategies for Prevention of HIV and Other Sexually Transmitted Infections. Journal of Sexually Transmitted Diseases 2016, pages 1-10.
Crossref
Crossref
Jafar Kafaie, Minsoo Kim & Erik Krause. (2016) Small Fiber Neuropathy Following Vaccination. Journal of Clinical Neuromuscular Disease 18:1, pages 37-40.
Crossref
Crossref
Derek B. Allison & Zahra Maleki. (2016) HPV-related head and neck squamous cell carcinoma: An update and review. Journal of the American Society of Cytopathology 5:4, pages 203-215.
Crossref
Crossref
Cloe S. Pogoda, Richard B. S. Roden & Robert L. Garcea. (2016) Immunizing against Anogenital Cancer: HPV Vaccines. PLOS Pathogens 12:5, pages e1005587.
Crossref
Crossref
José Enrique Eizayaga & Silvia Waisse. (2016) What do homeopathic doctors think of vaccines? An international online survey. Homeopathy 105:2, pages 180-185.
Crossref
Crossref
Hyeyeon Chang, Hye Lim Lee, Minju Yeo, Ji Seon Kim, Dong-Ick Shin, Sang-Soo Lee & Sung-Hyun Lee. (2016) Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations. Clinical Neurology and Neurosurgery 144, pages 126-128.
Crossref
Crossref
Mandy A. Allison, Laura P. HurleyLauri Markowitz, Lori A. CraneMichaela Brtnikova, Brenda L. Beaty, Megan Snow, Janine Cory, Shannon Stokley, Jill Roark & Allison Kempe. (2016) Primary Care Physicians’ Perspectives About HPV Vaccine. Pediatrics 137:2.
Crossref
Crossref
A Handisurya, C Schellenbacher, A Haitel, T Senger & R Kirnbauer. (2016) Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids. British Journal of Cancer 114:4, pages 409-416.
Crossref
Crossref
Miriam Nakalembe, Florence M. Mirembe & Cecily Banura. (2015) Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy. Infectious Agents and Cancer 10:1.
Crossref
Crossref
Susan Thrane, Christoph M. Janitzek, Mette Ø. Agerbæk, Sisse B. Ditlev, Mafalda Resende, Morten A. Nielsen, Thor G. Theander, Ali Salanti & Adam F. Sander. (2015) A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA. PLOS ONE 10:11, pages e0143071.
Crossref
Crossref
Julia M.L. Brotherton & Gina S. Ogilvie. (2015) Current status of human papillomavirus vaccination. Current Opinion in Oncology 27:5, pages 399-404.
Crossref
Crossref
C. Moreman, C. W. E. Redman & E. L. Moss. (2015) Human Papillomavirus and Its Role in Cervical Cancer Screening and Treatment. Current Treatment Options in Infectious Diseases 7:3, pages 217-229.
Crossref
Crossref
Laia Bruni, Beatriz Serrano, Xavier Bosch & Xavier Castellsagué. (2015) Vacuna frente al virus del papiloma humano. Eficacia y seguridad. Enfermedades Infecciosas y Microbiología Clínica 33:5, pages 342-354.
Crossref
Crossref
Aruna Nigam, Pikee Saxena & Anita S. Acharya. (2015) HPV vaccination and HPV DNA testing: Need of the hour. Indian Journal of Medical Specialities 6:1, pages 1-3.
Crossref
Crossref